Vancomycin Bayesian Renal Dose Adjustment

Adjust vancomycin dosing in renal impairment using Bayesian pharmacokinetic principles and estimated creatinine clearance to maintain therapeutic AUC24 targets while preventing nephrotoxicity in CKD and AKI patients.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Adjust vancomycin dosing in renal impairment using Bayesian pharmacokinetic principles and estimated creatinine clearance to maintain therapeutic AUC24 targets while preventing nephrotoxicity in CKD and AKI patients

Each component has a specific meaning:

  • Bayesian pharmacokinetic principles — The bayesian pharmacokinetic principles recorded for the scenario being assessed.
  • Estimated creatinine clearance — The estimated creatinine clearance recorded for the scenario being assessed.

Note: Interpret the vancomycin renal dose result against the thresholds and context described above.

How to Use

Enter the Bayesian pharmacokinetic principles, estimated creatinine clearance for the scenario you are assessing. Adjust vancomycin dosing in renal impairment using Bayesian pharmacokinetic principles and estimated creatinine clearance to maintain therapeutic AUC24 targets while preventing nephrotoxicity in CKD and AKI patients. Use the vancomycin renal dose result to inform your calculation.

Frequently Asked Questions